These agents include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound), which also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor
Cleveland Clinic, 2024)
Thats certainly more than we can say for some providers, like Strut, whose pricing is attractive at the outset but gets more convoluted as you titrate up to a maintenance dose
Its clinical reach remains specific to the population studied, the medication dose, and the cognitive behavioral therapy provided alongside it
Higher doses of semaglutide, such as those in Wegovy, are associated with a greater likelihood of fatigue compared to lower doses like Ozempic